These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 37082578)
1. African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A. Siddappa M; Hussain S; Wani SA; White J; Tang H; Gray JS; Jafari H; Wu HC; Long MD; Elhussin I; Karanam B; Wang H; Morgan R; Hardiman G; Adelani IB; Rotimi SO; Murphy AR; Nonn L; Davis MB; Kittles RA; Hughes Halbert C; Sucheston-Campbell LE; Yates C; Campbell MJ Cancer Res Commun; 2023 Apr; 3(4):621-639. PubMed ID: 37082578 [TBL] [Abstract][Full Text] [Related]
2. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes. Seuter S; Pehkonen P; Heikkinen S; Carlberg C Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200 [TBL] [Abstract][Full Text] [Related]
3. Differential gene regulation by a synthetic vitamin D receptor ligand and active vitamin D in human cells. Iwaki M; Kanemoto Y; Sawada T; Nojiri K; Kurokawa T; Tsutsumi R; Nagasawa K; Kato S PLoS One; 2023; 18(12):e0295288. PubMed ID: 38091304 [TBL] [Abstract][Full Text] [Related]
4. A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Warwick T; Schulz MH; Günther S; Gilsbach R; Neme A; Carlberg C; Brandes RP; Seuter S Sci Rep; 2021 Mar; 11(1):6518. PubMed ID: 33753848 [TBL] [Abstract][Full Text] [Related]
5. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer. Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529 [TBL] [Abstract][Full Text] [Related]
7. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714 [TBL] [Abstract][Full Text] [Related]
8. VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription. Singh PK; Long MD; Battaglia S; Hu Q; Liu S; Sucheston-Campbell LE; Campbell MJ Epigenetics; 2015; 10(1):40-9. PubMed ID: 25494645 [TBL] [Abstract][Full Text] [Related]
9. Genomic and epigenomic active vitamin D responses in human colonic organoids. Li J; Witonsky D; Sprague E; Alleyne D; Bielski MC; Lawrence KM; Kupfer SS Physiol Genomics; 2021 Jun; 53(6):235-248. PubMed ID: 33900108 [TBL] [Abstract][Full Text] [Related]
10. Prostatic compensation of the vitamin D axis in African American men. Richards Z; Batai K; Farhat R; Shah E; Makowski A; Gann PH; Kittles R; Nonn L JCI Insight; 2017 Jan; 2(2):e91054. PubMed ID: 28138564 [No Abstract] [Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. Kim S; Shevde NK; Pike JW J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825 [TBL] [Abstract][Full Text] [Related]
12. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193 [TBL] [Abstract][Full Text] [Related]
13. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Skowronski RJ; Peehl DM; Feldman D Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193 [TBL] [Abstract][Full Text] [Related]
14. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. Murthy S; Agoulnik IU; Weigel NL Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Skowronski RJ; Peehl DM; Feldman D Endocrinology; 1993 May; 132(5):1952-60. PubMed ID: 7682937 [TBL] [Abstract][Full Text] [Related]
16. Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer. Long MD; Campbell MJ J Steroid Biochem Mol Biol; 2017 Oct; 173():130-138. PubMed ID: 28027912 [TBL] [Abstract][Full Text] [Related]
17. The impact of chromatin organization of vitamin D target genes. Carlberg C; Dunlop TW Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674 [TBL] [Abstract][Full Text] [Related]
18. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237 [TBL] [Abstract][Full Text] [Related]
19. Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns. Doig CL; Singh PK; Dhiman VK; Thorne JL; Battaglia S; Sobolewski M; Maguire O; O'Neill LP; Turner BM; McCabe CJ; Smiraglia DJ; Campbell MJ Carcinogenesis; 2013 Feb; 34(2):248-56. PubMed ID: 23087083 [TBL] [Abstract][Full Text] [Related]
20. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]